All issues

Important!

This information is intended for healthcare professionals only!

2011 №4 (5)

- ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).

2011 №3 (4)

- An update on the relationships between rheumatoid arthritis and atherosclerosis
- Flowmetric study with hyaluronidase and chondroitin sulfate demonstrates the partaking of endothelial glycocalyx in microcirculation disturbances
- Lipoprotein associated phospholipase A2: role in atherosclerosis and utility as a biomarker for cardiovas-cular risk
- Acute coronary syndrome. What is the place of statins?
- Metabolic syndrome: the problem of the hepatotoxicity in patients treated with statins
- Diagnosis and treatment of family combined hyperlipidemia

Download Abstracts

2011 №2 (3)

- Functions and state of endothelial glycocalyx in the norm and pathology conditions
- Comparative evaluation of functional methods in the diagnosis of coronary artery disease
- Possibilites of PET for myocardial metabolism estimation
- Clinical and genetic aspects of primary dyslipidemia
- Intensive atorvastatin intake. Treatment efficiency improving
- Statins in rheumatology

Download Abstracts

2011 №1 (2)

- Lipoprotein(a) as a cardiovascular risk factor: current status
- Atorvastatin and fatty acids concentration in patients with IHD
- Contents of proinflammatory cytokines, chemoattractants and destructive metallopro-teinases in various tipes of unstable atherosclerotic plaques
- Visualization, composition and structure of endothelial glycocalyx
- Lipoprotein-associated phospholipase A2 – a new position in the risk stratification?
- Atherosclerosis and coronary heart disease: some aspects of pathogenesis (Review)
- The story of statins

Download Abstracts

2010 №1 (1)

- Identification of Patients at High Cardiovascular Risk: Problems and Possible Solutions. (Part I)
- Extracorporeal treatment of Refractory dyslipidemia
- Enhanced external counterpulsation for treatment patients with ischemic heart disease
- Atherogenous dyslipidemia and liver
- The influence of rosuvastatin treatment on atherosclerotic plaque stabilization
- Ezetimibe in clinical practice
- High doses of atorvastatin in patients with ischemic heart disease

Download Abstracts

Pages

Subscribe to All issues